Skip to main content
    P

    PolyPid (PYPD)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $6.54
    +0.39 (+6.34%)

    Market Cap: $129.92M

    Last updated: Nov 17, 2026 at 4:34 PM ET

    PolyPid (PYPD) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    PolyPid (PYPD) has a market cap of $129.92M. Its share count is up 18.07% from a year earlier.

    Total Valuation

    Market Cap$129.92M
    Latest price (Nov 17, 2026)$6.54

    Key Dates

    The next earnings report is expected on Feb 9, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateFeb 9, 2027 (expected)
    Last Earnings DateNov 11, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count rose 4.60% in the quarter ended Sep 30, 2026 and grew 92.93% a year over 2 years.

    Shares Outstanding23.68M
    Shares Change (YoY)+18.07%
    Shares Change (QoQ)+4.60%
    Share Count Growth (2Y CAGR)+92.93%

    Valuation Ratios

    Forward P/S11.5x
    P/B Ratio39.7x

    Price Statistics

    The stock is up 82.17% over 52 weeks and trades 20.89% above its 50-day average.

    Beta (1Y)0.84
    52-Week Change+82.17%
    1-Month Change+34.02%
    3-Month Change+30.54%
    6-Month Change+37.40%
    5-Year Change-97.48%
    Total Return (1Y)+82.17%
    Total Return (3Y CAGR)+18.80%
    Total Return (5Y CAGR)-50.48%
    Return vs SPY (1Y)+68.11%
    Max Drawdown (1Y)-32.97%
    Max Drawdown (3Y)-68.99%
    Sharpe Ratio (1Y)1.00
    Correlation with SPY (1Y)0.20
    50-Day Average$5.41
    200-Day Average$4.81
    52-Week Range$3.50 to $7.15
    RSI (14 Days)66.7
    Average Volume (20 Days)207.75K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 5.94x current liabilities.

    Current Ratio5.94x
    Quick Ratio5.66x

    Returns and Efficiency

    Return on equity is -764.01% and return on assets is -74.29% over the last 12 months.

    Return on Equity (ROE)-764.01%
    Return on Assets (ROA)-74.29%

    Scores

    PYPD has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income$149.00K
    Pretax Income-$29.88M
    Net Income-$29.80M
    Reported EPS (TTM)-$1.35

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Shareholder equity funds 9.72% of the $40.12M in total assets.

    Cash and Equivalents$5.62M
    Working Capital$27.58M
    Shareholder Equity$3.90M
    Book Value Per Share$0.16
    Total Assets$40.12M
    Total Liabilities$36.22M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Capital Expenditures$0
    FCF Per Share-$2.83

    Trailing 12 months through Sep 30, 2026.

    Stock Splits

    The last split was a 1-for-30 reverse split on Sep 21, 2023.

    Last Split DateSep 21, 2023
    Split TypeReverse split
    Split Ratio1:30

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About PYPD

    What is PYPD's market cap?

    PolyPid has a market cap of $129.92M.

    How many shares of PYPD are outstanding?

    PolyPid has 23.68M shares outstanding. The count is up 18.07% from a year earlier.

    Does PYPD pay a dividend?

    No. PolyPid does not pay a dividend.